Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report

Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus

(2014) Kuniyoshi Kamiya et al.   Modern Rheumatology

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Rituximab Therapy for Refractory Thrombotic Thrombocytopenic Purpura and Autoimmune-Mediated Thrombocytopenia in Systemic Lupus Erythematosus

(2011) Aneley Hundae et al.   SOUTHERN MEDICAL JOURNAL

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

(2011) Hans-Peter Tony et al.   ARTHRITIS RESEARCH & THERAPY

Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade

(2010) G. K. Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

(2010) F. A. Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

(2010) G. K. Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia

(2010) William P. Maier et al.   ARTHRITIS AND RHEUMATISM

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

(2010) J. T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

(2010) Gabor G. Illei et al.   ARTHRITIS AND RHEUMATISM

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

(2010) Hyejung Jung et al.   ARTHRITIS AND RHEUMATISM

B Cell-Targeted Therapies for Systemic Lupus Erythematosus

(2010) R. John Looney   DRUGS

Successful Treatment of Shrinking Lung Syndrome With Rituximab in a Patient With Systemic Lupus Erythematosus

(2010) Helen Benham et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis

(2010) T. Lee et al.   LUPUS

Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis

(2010) CM Lanata et al.   LUPUS

Treatment of cutaneous lupus erythematosus

(2010) A. Kuhn et al.   LUPUS

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study

(2010) J. Zavada et al.   LUPUS

The red wolf remains a wily foe

(2010) Peter E. Lipsky et al.   Nature Reviews Rheumatology

Cytokines as therapeutic targets in SLE

(2010) Lars Rönnblom et al.   Nature Reviews Rheumatology

Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases

(2010) J. Cortes-Hernandez et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts

(2010) T. Jonsdottir et al.   RHEUMATOLOGY

The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE

(2010) B. Griffiths et al.   RHEUMATOLOGY

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

(2009) M. Mosca et al.   ANNALS OF THE RHEUMATIC DISEASES

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

(2009) F A Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: A patient Delphi exercise

(2009) Bettina Bauernfeind et al.   ARTHRITIS AND RHEUMATISM

Neutralization of interferon-α/β-inducible genes and downstream effect in a phase I trial of an anti-interferon-α monoclonal antibody in systemic lupus erythematosus

(2009) Yihong Yao et al.   ARTHRITIS AND RHEUMATISM

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients

(2009) Tim Y.-T. Lu et al.   ARTHRITIS AND RHEUMATISM

Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: A five-year analysis of a large medicaid population

(2009) Tracy Li et al.   ARTHRITIS AND RHEUMATISM

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial

(2009) Ellen M. Ginzler et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Immunoadsorption for systemic lupus erythematosus

(2009) G.H. Stummvoll et al.   ATHEROSCLEROSIS SUPPLEMENTS

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

(2009) Thomas Dörner et al.   AUTOIMMUNITY REVIEWS

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

(2009) J. H. Rand et al.   BLOOD

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Guidelines for the diagnosis and treatment of pulmonary hypertension

(2009) et al.   EUROPEAN RESPIRATORY JOURNAL

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

(2009) D. Farge et al.   HAEMATOLOGICA

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the “CAPS Registry”

(2009) Ricard Cervera et al.   JOURNAL OF AUTOIMMUNITY

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy

(2009) H. A. Austin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis

(2009) Jai Radhakrishnan et al.   KIDNEY INTERNATIONAL

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

(2009) Kenneth R Carson et al.   LANCET ONCOLOGY

Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients

(2009) M. Garcia-Carrasco et al.   LUPUS

An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus

(2009) C Pena-Rossi et al.   LUPUS

Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside

(2009) G Zandman-Goddard et al.   LUPUS

Efficacy and safety of infliximab in active SLE: a pilot study

(2009) SS Uppal et al.   LUPUS

B-cell-depletion therapy in SLE—what are the current prospects for its acceptance?

(2009) Catarina Favas et al.   Nature Reviews Rheumatology

The socioeconomic burden of SLE

(2009) Chak Sing Lau et al.   Nature Reviews Rheumatology

B-cell-directed therapies for autoimmune disease

(2009) Thomas Dörner et al.   Nature Reviews Rheumatology

Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids

(2009) R. Pepper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus

(2009) P. Letchumanan et al.   RHEUMATOLOGY

Adverse events and efficacy of TNF-  blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients

(2009) M. Aringer et al.   RHEUMATOLOGY

Predictors of major infections in systemic lupus erythematosus

(2009) Guillermo Ruiz-Irastorza et al.   ARTHRITIS RESEARCH & THERAPY

Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases

(2009) Sherine E Gabriel et al.   ARTHRITIS RESEARCH & THERAPY

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

(2008) R Cervera et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

(2008) Xavier Jais et al.   ARTHRITIS AND RHEUMATISM

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial

(2008) Paul R. Fortin et al.   ARTHRITIS AND RHEUMATISM

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

(2008) T. Alexander et al.   BLOOD

Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox

(2008) D.J. Wallace   LUPUS

Effects of rituximab on resistant SLE disease including lung involvement

(2008) JA Reynolds et al.   LUPUS

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study

(2008) SK Kwok et al.   LUPUS

Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)

(2008) Luis Fernando Pinto et al.   RESPIRATION

Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences

(2008) G. Ruiz-Irastorza et al.   RHEUMATOLOGY

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis

(2008) C.-C. Szeto et al.   RHEUMATOLOGY

Systemic lupus erythematosus in the elderly

(2007) J. Rovenský et al.   AUTOIMMUNITY REVIEWS

Letter to the Editor

(2007) N. Limal et al.   LUPUS